Giuseppe MILANO

Dr. Giuseppe MILANO

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2014 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Open access
PDF file
VCV. Campana
V. Campana
GMGiuseppe MILANO
Giuseppe MILANO
EPE. Pagano
E. Pagano
MBMarta Barba
Marta Barba
CCClaudia Cicione
Claudia Cicione
GLGiandomenico Logroscino
Giandomenico Logroscino
Bone substitutes are being increasingly used in surgery as over two millions bone grafting procedures are performed worldwide per year. Autografts still represent the gold standard for bone substitution, though the morbidity and the inherent limited availability are the main limitations. Allografts, i.e. banked bone, are osteoconductive and weakly osteoinductive, though there are still concerns about the residual infective risks, costs and donor availability issues. As an alternative, xenograft substitutes are cheap, but their use provided contrasting results, so far. Ceramic-based synthetic bone substitutes are alternatively based on hydroxyapatite (HA) and tricalcium phosphates, and are widely used in the clinical practice. Indeed, despite being completely resorbable and weaker than cortical bone, they have exhaustively proved to be effective. Biomimetic HAs are the evolution of traditional HA and contains ions (carbonates, Si, Sr, Fl, Mg) that mimic natural HA (biomimetic HA). Injectable cements represent another evolution, enabling mininvasive techniques. Bone morphogenetic proteins (namely BMP2 and 7) are the only bone inducing growth factors approved for human use in spine surgery and for the treatment of tibial nonunion. Demineralized bone matrix and platelet rich plasma did not prove to be effective and their use as bone substitutes remains controversial. Experimental cell-based approaches are considered the best suitable emerging strategies in several regenerative medicine application, including bone regeneration. In some cases, cells have been used as bioactive vehicles delivering osteoinductive genes locally to achieve bone regeneration. In particular, mesenchymal stem cells have been widely exploited for this purpose, being multipotent cells capable of efficient osteogenic potential. Here we intend to review and update the alternative available techniques used for bone fusion, along with some hints on the advancements achieved through the experimental research in this field.

1 May 2004 in Arthroscopy
Verified
Journal Article
Closed access
CFCarlo Fabbriciani
Carlo Fabbriciani
GMGiuseppe MILANO
Giuseppe MILANO
ADAntonio Demontis
Antonio Demontis
SFSalvatore Fadda
Salvatore Fadda
FZFabio Ziranu
Fabio Ziranu
PMPier Damiano Mulas
Pier Damiano Mulas

3 November 2008 in Arthroscopy
Verified
Journal Article
Closed access
AGAndrea Grasso
Andrea Grasso
GMGiuseppe MILANO
Giuseppe MILANO
MSMatteo Salvatore
Matteo Salvatore
GFGianluca Falcone
Gianluca Falcone
LDLaura Deriu
Laura Deriu
CFCarlo Fabbriciani
Carlo Fabbriciani

1 June 2006 in Arthroscopy
Verified
Journal Article
Closed access
GMGiuseppe MILANO
Giuseppe MILANO
PMPier Damiano Mulas
Pier Damiano Mulas
FZFabio Ziranu
Fabio Ziranu
SPStefano Piras
Stefano Piras
AMAndrea Manunta
Andrea Manunta
CFCarlo Fabbriciani
Carlo Fabbriciani

1 July 2010 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
GMGiuseppe MILANO
Giuseppe MILANO
EPE. Sanna Passino
E. Sanna Passino
LDL. Deriu
L. Deriu
GCG. Careddu
G. Careddu
LML. Manunta
L. Manunta
CFC. Fabbriciani
C. Fabbriciani

22 July 2015 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
MSMaristella F. Saccomanno
Maristella F. Saccomanno
GSGiuseppe Sircana
Giuseppe Sircana
GCGianpiero Cazzato
Gianpiero Cazzato
FDFabrizio Donati
Fabrizio Donati
PRPietro Randelli
Pietro Randelli
GMGiuseppe MILANO
Giuseppe MILANO